Inhibition of miR-10a-5p suppresses cholangiocarcinoma cell growth through downregulation of Akt pathway

References

• BlechaczBGoresGJCholangiocarcinoma: advances in pathogenesis, diagnosis, and treatmentHepatology200848130832118536057
   PubMed Web of Science ®Google Scholar
• RazumilavaNGoresGJCholangiocarcinomaLancet201438399352168217924581682
   PubMed Web of Science ®Google Scholar
• KoKSPengJYangHAnimal models of cholangiocarcinomaCurr Opin Gastroenterol201329331231823434850
   PubMed Web of Science ®Google Scholar
• RazumilavaNGoresGJClassification, diagnosis, and management of cholangiocarcinomaClin Gastroenterol Hepatol201311113.e121.e122982100
   PubMed Web of Science ®Google Scholar
• VogelAWegeHCacaKNashanBNeumannUThe diagnosis and treatment of cholangiocarcinomaDtsch Arztebl Int20141114474875425412632
   PubMed Web of Science ®Google Scholar
• ShaibYHEl-SeragHBDavilaJAMorganRMcGlynnKARisk factors of intrahepatic cholangiocarcinoma in the United States: a case-control studyGastroenterology2005128362062615765398
   PubMed Web of Science ®Google Scholar
• SahaSKZhuAXFuchsCSBrooksGAForty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the riseOncologist201621559459927000463
   PubMed Web of Science ®Google Scholar
• NajranPLamarcaAMullanDUpdate on treatment options for advanced bile duct tumours: radioembolisation for advanced cholangiocarcinomaCurr Oncol Rep20171975028656502
   PubMed Web of Science ®Google Scholar
• QureshiKJesudossRAl-OsaimiAMThe treatment of cholangiocarcinoma: a hepatologist’s perspectiveCurr Gastroenterol Rep2014161041225183579
   PubMedGoogle Scholar
• StrandDSCosgroveNDPatrieJTERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinomaGastrointest Endosc201480579480424836747
   PubMed Web of Science ®Google Scholar
• FelekkisKTouvanaEStefanouCDeltasCmicroRNAs: a newly described class of encoded molecules that play a role in health and diseaseHippokratia201014423624021311629
   PubMed Web of Science ®Google Scholar
• FangZRajewskyNThe impact of miRNA target sites in coding sequences and in 3′UTRsPLoS One201163e1806721445367
   PubMed Web of Science ®Google Scholar
• LiuQHeHZengTHuangZFanTWuQNeural-specific expression of miR-344-3p during mouse embryonic developmentJ Mol Histol201445436337224292630
   PubMed Web of Science ®Google Scholar
• KimJSChoiDWKimCSMicroRNA-203 induces apoptosis by targeting Bmi-1 in YD-38 oral cancer cellsAnticancer Res20183863477348529848700
   PubMed Web of Science ®Google Scholar
• HuTChongYLuSmiR-339 promotes development of stem cell leukemia/lymphoma syndrome via downregulation of the BCL2L11 and BAX pro-apoptotic genesCancer Res201878133522353129735550
   PubMed Web of Science ®Google Scholar
• LiuYHuangXTimaniKABroxmeyerHEHeJJMicroRNA-124 Targets Tip110 Expression and Regulates HematopoiesisStem Cells Dev201524172009201725928721
   PubMed Web of Science ®Google Scholar
• LindEFElfordAROhashiPSMicro-RNA 155 is required for optimal CD8+ T cell responses to acute viral and intracellular bacterial challengesJ Immunol201319031210121623275599
   PubMed Web of Science ®Google Scholar
• WangHLiCJianZOuYOuJTGF-β1 reduces miR-29a expression to promote tumorigenicity and metastasis of cholangiocarcinoma by targeting HDAC4PLoS One20151010e013670326441331
   PubMed Web of Science ®Google Scholar
• HanYMengFVenterJmiR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growthJ Hepatol20166461295130426923637
   PubMed Web of Science ®Google Scholar
• LiuCHHuangQJinZYCirculating microRNA-21 as a prognostic, biological marker in cholangiocarcinomaJ Cancer Res Ther201814122022529516989
   PubMed Web of Science ®Google Scholar
• Correa-GallegoCMaddaloDDoussotACirculating plasma levels of MicroRNA-21 and MicroRNA-221 are potential diagnostic markers for primary intrahepatic cholangiocarcinomaPLoS One2016119e016369927685844
   PubMed Web of Science ®Google Scholar
• LundAHmiR-10 in development and cancerCell Death Differ201017220921419461655
   PubMed Web of Science ®Google Scholar
• QuinonezSCInnisJWHuman HOX gene disordersMol Genet Metab2014111141524239177
   PubMed Web of Science ®Google Scholar
• CalinGASevignaniCDumitruCDHuman microRNA genes are frequently located at fragile sites and genomic regions involved in cancersProc Natl Acad Sci U S A200410192999300414973191
   PubMed Web of Science ®Google Scholar
• Gonzalez Dos AnjosLde AlmeidaBCGomes de AlmeidaTCould miRNA signatures be useful for predicting uterine sarcoma and carcinosarcoma prognosis and treatment?Cancers (Basel)2018109E31530200635
   PubMed Web of Science ®Google Scholar
• KimCGoEJKimARecurrence prediction using microRNA expression in hormone receptor positive breast cancer during tamoxifen treatmentBiomarkers Epub2018823
   Web of Science ®Google Scholar
• ZhuQGongLWangJmiR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1)BMC Cancer201616180627756250
   PubMed Web of Science ®Google Scholar
• LuoLYuZPQinHExosomal MicroRNA-10a Is Associated with Liver Regeneration in Rats through Downregulation of EphA4Chin Med J (Engl)2018131445446029451151
   PubMed Web of Science ®Google Scholar
• TangtanatakulPThammasateBJacquetATranscriptomic profiling in human mesangial cells using patient-derived lupus autoantibodies identified miR-10a as a potential regulator of IL8Sci Rep2017711451729109423
   PubMed Web of Science ®Google Scholar
• LuoLChenBLiSPlasma miR-10a: a potential biomarker for coronary artery diseaseDis Markers20162016384192727313333
   PubMed Web of Science ®Google Scholar
• MuNGuJHuangTA novel NF-κB/YY1/microRNA-10a regulatory circuit in fibroblast-like synoviocytes regulates inflammation in rheumatoid arthritisSci Rep201662005926821827
   PubMed Web of Science ®Google Scholar
• XiongGHuangHFengMMiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinomaJ Exp Clin Cancer Res20183717629615098
   PubMed Web of Science ®Google Scholar
• BiLSunLJinZZhangSShenZMicroRNA-10a/b are regulators of myeloid differentiation and acute myeloid leukemiaOncol Lett20181545611561929552198
   PubMed Web of Science ®Google Scholar
• HagaHYanITakahashiKWoodJPatelTEmerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinomaGene Expr2014162939924801170
   PubMed Web of Science ®Google Scholar
• TaoRKrishnanSBhosalePRAblative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: a retrospective dose response analysisJ Clin Oncol201634321922626503201
   PubMed Web of Science ®Google Scholar
• ChenXChenJLiuXGuoZSunXZhangJThe real-time dynamic monitoring of microRNA function in cholangiocarcinomaPLoS One201496e9943124918778
   PubMed Web of Science ®Google Scholar
• YanYLuoYCWanHYMicroRNA-10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4-mediated epithelial-mesenchymal transition and adhesion in hepatoma cellsHepatology201357266767722996586
   PubMed Web of Science ®Google Scholar
• HussainNZhuWJiangCDown-regulation of miR-10a-5p promotes proliferation and restricts apoptosis via targeting T-box transcription factor 5 in inflamed synoviocytesBiosci Rep2018382BSR2018000329545315
   PubMed Web of Science ®Google Scholar
• ManningBDTokerAAKT/PKB signaling: navigating the networkCell2017169338140528431241
   PubMed Web of Science ®Google Scholar
• YothaisongSDokduangHTechasenAIncreased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategyTumour Biol20133463637364823832540
   PubMedGoogle Scholar
• GeorgescuMMPTEN tumor suppressor network in PI3K-Akt pathway controlGenes Cancer20101121170117721779440
   PubMedGoogle Scholar
• PengYCroceCMThe role of MicroRNAs in human cancerSignal Transduct Target Ther201611500429263891
   PubMed Web of Science ®Google Scholar
• MengFHensonRWehbe-JanekHGhoshalKJacobSTPatelTMicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancerGastroenterology2007133264765817681183
   PubMed Web of Science ®Google Scholar
• WangLJHeCCSuiXMiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTENOncotarget2015685932594625803229
   PubMed Web of Science ®Google Scholar
• LiJYaoLLiGmiR-221 promotes epithelial-mesenchymal transition through targeting PTEN and forms a positive feedback loop with β-catenin/c-Jun signaling pathway in extra-hepatic cholangiocar-cinomaPLoS One20151010e014116826501139
   PubMed Web of Science ®Google Scholar
• ZhuHHanCLuDWuTmiR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activatorAm J Pathol2014184102828283925239565
   PubMed Web of Science ®Google Scholar
• JiWSunBSuCTargeting microRNAs in cancer gene therapyGenes (Basel)201781E2128075356
   PubMed Web of Science ®Google Scholar